Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04782622
Status:
UNKNOWN
Last Update Posted:
2021-03-04
First Post:
2021-02-23
Brief Title:
The Combination of Apatinib and Camerlizumab for Advanced Lung Cancer Patients With Muti-line Therapy
Sponsor:
The Affiliated Hospital of Qingdao University
Organization:
The Affiliated Hospital of Qingdao University
Organization Data
Organization:
The Affiliated Hospital of Qingdao University
Class:
OTHER
Study ID:
ApatPEM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Affiliated Hospital of Qingdao University
Lead Sponsor Class:
OTHER
Responsible Party:
zhangxiaochun
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The Affiliated Hospital of Qingdao University
Old Name:
None
Old Organization:
None